AngioDynamics
ANGO
135 hedge funds and large institutions have $205M invested in AngioDynamics in 2024 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 48 increasing their positions, 59 reducing their positions, and 28 closing their positions.
31% more call options, than puts
Call options by funds: $21K | Put options by funds: $16K
6.96% less ownership
Funds ownership: 94.36% → 87.4% (-7%)
10% less funds holding
Funds holding: 150 → 135 (-15)
19% less repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 59
30% less capital invested
Capital invested by funds: $294M → $205M (-$89.7M)
46% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 28
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCMI
Paradigm Capital Management Inc
Albany,
New York
|
+$6.41M |
| 2 |
RA
Royce & Associates
New York
|
+$3.06M |
| 3 |
WSL
Western Standard LLC
Los Angeles,
California
|
+$2.79M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$2.13M |
| 5 |
Renaissance Technologies
New York
|
+$1.63M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$11.3M |
| 2 |
Millennium Management
New York
|
-$3.4M |
| 3 |
ECM
ExodusPoint Capital Management
New York
|
-$2.61M |
| 4 |
HA
Heartland Advisors
Milwaukee,
Wisconsin
|
-$2.43M |
| 5 |
JGC
J. Goldman & Co
New York
|
-$2.39M |
ANGO Hedge Fund Activity: Q1 2024 in Review
135 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in AngioDynamics (ANGO) for Q1 2024, worth a combined $205M — down 30% from $294M a quarter earlier.
Sellers outnumbered buyers: 28 funds closed out of ANGO and 15 opened new positions — a net loss of 13 holders — while 59 trimmed existing stakes and 48 added.
The largest buyer was Paradigm Capital Management Inc, opening a new position worth an estimated $6.41M. The largest seller was Morgan Stanley, cutting an estimated $11.3M.
- 135 institutional investors held AngioDynamics (ANGO) as of Q1 2024, down from 150 in Q4 2023.
- Funds reported $205M of AngioDynamics stock for Q1 2024, down 30% quarter-over-quarter.
- 15 funds opened new AngioDynamics positions in Q1 2024 and 28 closed out, a net change of -13 holders.
- The largest AngioDynamics buyer in Q1 2024 was Paradigm Capital Management Inc, an estimated $6.41M added.
- The largest AngioDynamics seller in Q1 2024 was Morgan Stanley, an estimated $11.3M sold.
Based on aggregated 13F filings for Q1 2024.